Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
about
Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growthCIB1 is a regulator of pathological cardiac hypertrophyCardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein HopOngoing controversies surrounding cardiac remodeling: is it black and white-or rather fifty shades of gray?Mechanisms of altered Ca²⁺ handling in heart failureModulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivoEstrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurinPak1 as a novel therapeutic target for antihypertrophic treatment in the heartAttenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-discNFATc1 regulates lymphatic endothelial developmentImpaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient miceSumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy.Distinctive profile of IsomiR expression and novel microRNAs in rat heart left ventricle.ERβ selective agonist inhibits angiotensin-induced cardiovascular pathology in female miceNuclear factor of activated T cells mediates fluid shear stress- and tensile strain-induced Cox2 in human and murine bone cells.Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibitionCalcineurin signaling and PGC-1alpha expression are suppressed during muscle atrophy due to diabetes.Regulation of calcineurin through transcriptional induction of the calcineurin A beta promoter in vitro and in vivo.Calcineurin protects the heart in a murine model of dilated cardiomyopathy.Influence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheepThe IP3 receptor regulates cardiac hypertrophy in response to select stimuli.Evolutionarily conserved role of calcineurin in phosphodegron-dependent degradation of phosphodiesterase 4DCardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophyMeeting of the minds: metalloneurochemistryDual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy.Calcineurin and cardiac hypertrophy: where have we been? Where are we going?Nutritional intervention restores muscle but not kidney phenotypes in adult calcineurin Aα null mice.The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland.Compensatory renal hypertrophy following uninephrectomy is calcineurin-independent.Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted miceCardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling moleculesCalcineurin A-alpha but not A-beta is required for normal kidney development and functionAKAPs: the architectural underpinnings of local cAMP signaling.Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.Protein kinase C (PKC)ζ-mediated Gαq stimulation of ERK5 protein pathway in cardiomyocytes and cardiac fibroblasts.
P2860
Q24309615-45C488C9-ED19-403E-A798-93C515DD2B99Q24338983-30A0A8B4-8165-4083-A859-31443505FCDFQ24682945-0DC5C0CA-CD1B-4D28-8B0A-EB892F30026CQ26800197-6FA71EF6-2DA7-4852-A3B7-031B1246C0E2Q27012758-E885B18F-0557-4DDB-98C9-1AB409EEAD06Q28505205-B769D8EA-06F4-47E2-9F66-132980CD2DDBQ28568314-7B0FB6E4-64F7-461C-BA23-273278F4DA68Q28581667-87197377-1582-4A5C-B55A-669C69FF7EE9Q28583542-D7C6769C-AD90-4163-AFEC-DAF8BA86B8C3Q28593396-1B5C0FDC-B76E-471C-9C68-BFCDFFA136BDQ28593523-5D293997-16A8-4290-9190-A06489748E2CQ30491332-D840287A-DA5D-4B97-A964-8C800BF86FE1Q30825127-A5FD42CA-2288-4F8E-A3DA-AC6A1683F12DQ31120462-63CF38D1-A218-4FA7-96F5-E158E8905D71Q33584903-B9A91459-82CC-4488-996A-F1FC1C4312D8Q33636940-34218584-FA5B-45A8-809C-7B90A5EE9288Q33713890-C48800E9-4334-4850-AEA0-A8A890A002F7Q33724430-07AA3CDB-7DF7-481A-A42E-DA6084BE9F5DQ33912897-F9926643-D6EF-4AD7-8B5E-72FEDD50AF90Q33925316-CF0F9DAE-608C-4636-874C-C3578F473131Q33936214-CDED5D8E-8AFC-4B5B-94F7-0173650DA8E5Q33983596-4752D095-668D-41C6-953C-210F5BB5DB0BQ34103732-CF0FA5BB-2685-4216-9DC0-66A97C1664C5Q34119706-96AE453A-20D6-4C92-BEAF-3C034E629DB7Q34160636-C6D03011-065D-44A3-A091-958C1B3C1F2BQ34185781-A312E742-6768-4CD2-B91D-DE07E2C2BE9AQ34470478-5A7E6D47-63D9-4979-8679-1F01F9DFC065Q34641729-58CA0CFA-98F6-4E5D-BDB6-7250BA2735E6Q34701648-37BF6968-48F4-4455-A4AD-C1BAC1C03B55Q34778695-25BCABBF-300B-4A8E-9EB6-CF984363B9C5Q34805437-9978A865-B94A-42C2-88AC-71AB28D6BE60Q34998348-448AD580-80B1-4277-9D9D-A9DBC3ED192AQ35019954-7C6F3C5F-1DB7-441C-A1F3-083F71CAD008Q35047672-94687236-8EF8-47D2-A48C-7A2AB7D8D06AQ35056963-0AA2410A-2A23-4261-9A56-CABBA22686BEQ35103375-5BDE2D0D-40FA-44E1-BF1B-86226A97840BQ35201356-891C27E3-6A4B-48C8-A1ED-FBCDC2060AEAQ35558302-E6990A07-E5B0-40EB-AC12-AD63D2588902Q35592155-24B661D3-78EA-4E1A-8FED-0E9FF2E530EAQ35801964-5FDF5FA8-2973-4DE6-ACC1-ADF16B3CE8A3
P2860
Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
description
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2002
@ast
im April 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/04/02)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/04/02)
@nl
наукова стаття, опублікована у квітні 2002
@uk
name
Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
@ast
Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
@en
Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
@nl
type
label
Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
@ast
Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
@en
Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
@nl
prefLabel
Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
@ast
Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
@en
Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
@nl
P2093
P2860
P3181
P356
P1476
Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice
@en
P2093
Benjamin J Wilkins
Betty J Glascock
John N Lorenz
Kevin M Tymitz
Orlando F Bueno
Thomas F Kimball
P2860
P304
P3181
P356
10.1073/PNAS.072647999
P407
P577
2002-03-19T00:00:00Z